MeiraGTx Holdings plc (MGTX)
Last updated: 2026-10-20 18:44:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
MeiraGTx Holdings plc (MGTX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $10.01, with a market capitalization of $891.28M and a P/E ratio of 11.49. Over the past 52 weeks, its price has ranged from $6.62 to $15.35. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$891.28M | |
$9.45 | |
$30.23 | |
$3.49 | |
$9.45 | |
401.78K | |
792.71K | |
11.49 | |
$15.35 | |
$6.62 | |
-- | |
-- |
MeiraGTx Holdings plc (MGTX) Stock Price Today
MeiraGTx Holdings plc (MGTX) is currently trading at $10.01 as of 2026-10-20 18:28:46, up 5.93% ($0.56) from the previous close of $9.45
During today's regular trading session, MGTX has traded between $3.49 and $30.23, with a trading volume of 401.78K shares. The current price is near the lower end of today's range.
MeiraGTx Holdings plc (MGTX) 7-Day Stock Price Change
Over the past seven days, MeiraGTx Holdings plc (MGTX) moved from $10.69 to $10.01, representing a decline of 6.36% ($0.68).
The stock traded between $9.25 and $10.99 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 788.35 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
MGTX 52-Week Price Position
Position in Range: 38.8%
MGTX is currently trading at $10.01, placing it 38.8% of the way from its 52-week low of $6.62 to its 52-week high of $15.35. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is MeiraGTx Holdings plc (MGTX)?
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
MeiraGTx Holdings plc Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 393 |
| Exchange | NASDAQ |
| Company Website |
How to Buy MeiraGTx Holdings plc (MGTX) Stock on MEXC
Eligible investors can buy real shares of MeiraGTx Holdings plc (MGTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is MeiraGTx Holdings plc (MGTX) stock price today?
2.Is MGTX stock going up or down today?
3.What is MGTX pre-market price?
4.What is MGTX after-hours price?
5.Is MGTX stock trading now?
6.Where does MGTX sit relative to its 52-week high and low?
7.What sector is MeiraGTx Holdings plc in?
8.What is MeiraGTx Holdings plc's market capitalization and where is it listed?
9.How is MGTX valued in terms of P/E ratio and EPS?
10.Does MeiraGTx Holdings plc pay a dividend?
Explore More US Stocks
Search Stocks
MGTX Stock Calculator
Estimate the value between MGTX shares and USD.
MGTX Shares to USD
1.00 MGTX shares = 10.01 USD
Calculations are estimates based on the latest available price and are for reference only.


